Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAKAR HEALTHCARE vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SAKAR HEALTHCARE    ACTAVIS
EQUITY SHARE DATA
    SAKAR HEALTHCARE
Mar-23
ACTAVIS
Dec-18
SAKAR HEALTHCARE /
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs29516,111-   
Low Rs11210,807-   
Sales per share (Unadj.) Rs70.03,952.0-  
Earnings per share (Unadj.) Rs6.7-1,272.9-  
Cash flow per share (Unadj.) Rs14.6416.5-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs91.016,300.0-  
Shares outstanding (eoy) m19.04332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.93.4 85.3%   
Avg P/E ratio x30.4-10.6 -287.1%  
P/CF ratio (eoy) x14.032.3 43.2%  
Price / Book Value ratio x2.20.8 270.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,8734,476,456 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m1580-   
Avg. sales/employee Rs Th077,776.7-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,051.9-  
INCOME DATA
Net Sales Rs m1,3341,314,426 0.1%  
Other income Rs m4725,136 0.2%   
Total revenues Rs m1,3801,339,562 0.1%   
Gross profit Rs m33334,445 1.0%  
Depreciation Rs m150561,888 0.0%   
Interest Rs m6075,850 0.1%   
Profit before tax Rs m170-578,157 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,453 0.0%   
Tax Rs m42-7,327 -0.6%   
Profit after tax Rs m128-423,377 -0.0%  
Gross profit margin %24.92.6 951.9%  
Effective tax rate %24.91.3 1,965.7%   
Net profit margin %9.6-32.2 -29.7%  
BALANCE SHEET DATA
Current assets Rs m559539,109 0.1%   
Current liabilities Rs m545476,913 0.1%   
Net working cap to sales %1.14.7 22.6%  
Current ratio x1.01.1 90.8%  
Inventory Days Days2920 150.4%  
Debtors Days Days60466 911.2%  
Net fixed assets Rs m2,804148,786 1.9%   
Share capital Rs m1900-   
"Free" reserves Rs m1,5430-   
Net worth Rs m1,7335,421,392 0.0%   
Long term debt Rs m9821,909,069 0.1%   
Total assets Rs m3,3638,474,869 0.0%  
Interest coverage x3.8-6.6 -58.1%   
Debt to equity ratio x0.60.4 160.9%  
Sales to assets ratio x0.40.2 255.6%   
Return on assets %5.6-4.1 -135.7%  
Return on equity %7.4-7.8 -94.2%  
Return on capital %8.5-4.8 -174.6%  
Exports to sales %78.40-   
Imports to sales %00-   
Net fx Rs m6900-   
CASH FLOW
From Operations Rs m333469,595 0.1%  
From Investments Rs m-744257,981 -0.3%  
From Financial Activity Rs m411-805,965 -0.1%  
Net Cashflow Rs m1-77,998 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.26 Rs / USD

Compare SAKAR HEALTHCARE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SAKAR HEALTHCARE With: IND. SWIFT  CONCORD DRUGS  AMI ORGANICS  GODAVARI DRU  MANGALAM DRUGS  



Today's Market

Gift Nifty Down 39 Points | Page Industries Q4 Results | ITC to Seek Demerger Approval | Top Buzzing Stocks Today Gift Nifty Down 39 Points | Page Industries Q4 Results | ITC to Seek Demerger Approval | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended on firm footing.